论文部分内容阅读
[目的]观察丹参川芎注射液联合低分子肝素治疗34例不稳定型心绞痛(UA)的临床疗效以及探讨他们的药理作用。[方法]将68例不稳定型绞痛患者随机分为对照组和治疗组,两组各34例。两组均常规给予相同的综合治疗措施,治疗组在常规治疗的基础上加用丹参川芎嗪注射液及低分子肝素。[结果]治疗组心绞痛发作次数、心肌缺血时间及血脂的变化都明显优于对照组(P﹤0.01)。[结论]丹参川芎嗪注射液联合低分子肝素钙治疗不稳定型心绞痛疗效确切。
[Objective] To observe the clinical efficacy of Salvia Chuanxiong Injection combined with low molecular weight heparin in the treatment of 34 patients with unstable angina pectoris (UA) and explore their pharmacological effects. [Methods] 68 patients with unstable angina were randomly divided into control group and treatment group, 34 cases in each group. Both groups were routinely given the same comprehensive treatment, the treatment group on the basis of conventional treatment plus Salvia Ligustrazine injection and low molecular weight heparin. [Results] The number of angina attacks, myocardial ischemia time and blood lipids in the treatment group were significantly better than those in the control group (P <0.01). [Conclusion] Danshen ligustrazine injection and low molecular weight heparin calcium are effective in treating unstable angina pectoris.